Century Therapeutics to Present at the LifeSci Partners 2nd Annual Genetic Medicines Symposium

Posted: June 22, 2022 at 2:43 am

PHILADELPHIA, June 21, 2022 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today announced that Lalo Flores, Ph.D., Chief Executive Officer, will participate in a fireside chat at the LifeSci Partners 2nd Annual Genetic Medicines Symposium on June 28, 2022, at 9:30 AM ET.

More here:
Century Therapeutics to Present at the LifeSci Partners 2nd Annual Genetic Medicines Symposium

Related Posts